TVM Capital Life Science
TVM Capital Life Science is a dedicated life science venture capital firm, with offices in Montreal, Canada and Munich, Germany.
Business Model:
Revenue: $13.3M
Employees: 2-10
Rankings
Industries / Tags:
Detailed TVM Capital Life Science Information
Geographic Data
Address: Ottostraße 4
City: Munich
State: bavaria
Zip: 80333
Country: DE
Financial Info
Stage:
Raised Last:
$0
Raised Total:$680M
Social
Twitter
Linkedin
Crunchbase
Metrics
7,534,583Website Global Rank
505Website Monthly Traffic
Twitter Followers
Description
TVM Capital Life Science is a dedicated life science venture capital firm, with offices in Montreal, Canada and Munich, Germany. Since inception, TVM Capital Life Science has invested in entrepreneurial venture backed companies. Over several fund generations, their investment strategy has included a multi-stage investment approach spanning discovery to market ready companies as well as profitable companies searching for growth capital. Their investment focus has always been broad and includes investments in therapeutics, technology platforms, medtech and diagnostics. They invest in Canada, the U.S., Germany and Western Europe with their dedicated team of investment professionals based in Montreal and Munich.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 8/2013 | Ixchelsis | Venture Round | - |
| 1/2015 | CoLucid Pharmaceuticals | Series C | 0 |
| 2/2021 | Vespina Lifesciences | Venture Round | - |
| 9/2016 | AurKa Pharma | Venture Round | - |
| 12/2016 | Ixchelsis | Venture Round | 12M |
| 4/2015 | Esperas Pharma | Venture Round | - |
| 3/2022 | Egg Medical | Venture Round | 13M |
| 12/2016 | AL-S Pharma | Seed Round | - |
| 2/2022 | Centogene | Post-IPO Equity | 0 |
| 3/2021 | Access Vascular | Series B | 0 |
| 9/2017 | Acer Therapeutics | Post-IPO Equity | 0 |
| 6/2017 | Centogene | Series A | 0 |
| 4/2020 | leon nanodrugs | Series B | - |
| 7/2015 | leon nanodrugs | Series A | 0 |
| 3/2019 | Emovi | Series C | 11.3M |
| 10/2017 | Panthera Dental inc | Venture Round | - |
| 2/2021 | Kent Imaging | Venture Round | 0 |
| 5/2016 | Acer Therapeutics | Post-IPO Equity | 8.1M |
| 3/2022 | Egg Medical | Venture Round | 0 |
| 2/2022 | Centogene | Post-IPO Equity | 0 |
| 3/2021 | Access Vascular | Series B | 0 |
| 2/2021 | Kent Imaging | Venture Round | 0 |
| 2/2021 | Vespina Lifesciences | Venture Round | - |
| 4/2020 | leon nanodrugs | Series B | - |
| 3/2019 | Emovi | Series C | 0 |
| 10/2017 | Panthera Dental inc | Venture Round | - |
| 9/2017 | Acer Therapeutics | Post-IPO Equity | 0 |
| 6/2017 | Centogene | Series A | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
